Health experts slam US deal for large supply of virus drug

Health experts slam US deal for large supply of virus drug

LONDON — Public health experts on Wednesday criticized the U.S. for securing a large supply of the only drug licensed so far to treat COVID-19.

The U.S. government announced this week that it had an agreement with Gilead Sciences to make the bulk of their production of remdesivir for the next three months available to Americans. The Department of Health and Human Services said it had secured 500,000 treatments through September, which amounts to all but 10% of production in August and September.

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it,” Health and Human Services Secretary Alex Azar said in a statement.

Ohid Yaqub, a senior lecturer at the University of Sussex, called the U.S. agreement “disappointing news.”

“It so clearly signals an unwillingness to co-operate with other countries and the chilling effect this has on international agreements about intellectual property rights,” Yaqub said in a statement

Until now, Gilead had donated the drug. That ended Tuesday and Gilead this week set the price for new shipments at $2,300 to $3,100 per treatment course. The company is allowing generic makers to supply the drug at much lower prices to 127 poor or middle-income countries.

In a statement Wednesday, the California-based Gilead said its agreement with the U.S. allows for any unneeded supplies to be sent to other countries. The company said it is “working as quickly as possible” to enable access worldwide. But it noted that U.S. is seeing a significant rise in COVID-19 cases, while “most EU and other developed countries have reduced their levels of disease considerably.”

Early studies testing remdesivir in patients hospitalized with COVID-19 found that those who received the treatment recovered quicker than those who didn’t. It is the only drug licensed by both the U.S. and the European Union as a treatment for those with severe illness from the coronavirus.

Dr. Peter Horby, who is running a large study testing several treatments for COVID-19, told the BBC that “a stronger framework” was needed to ensure fair prices and access to key medicines for people and nations around the world. He said that as an American company, Gilead was likely under “certain political pressures locally.”

British Prime Minister Boris Johnson’s spokesman, James Slack, declined to criticize the United States for the move. He said the U.K. had a “sufficient stock” of remdesivir for patients who need it, but didn’t specify how much that was.

Thomas Senderovitz, head of the Danish Medicines Agency, told Danish broadcaster DR that the move could endanger Europeans and others down the road.

“I have never seen anything like that. That a company chooses to sell their stock to only one country. It’s very strange and quite inappropriate,” he said. “Right now we have enough to make it through the summer if the intake of patients is as it is now. If a second wave comes, we may be challenged.”

Dr. Michael Ryan, the emergencies chief of the World Health Organization, said the agency was looking into the implications of the U.S. deal for remdesivir.

“There are many people around the world who are very sick …. and we want to ensure that everybody has access to the necessary, life-saving interventions.” He said WHO was “fully committed” to working toward equitable access for such treatments.

Gilead had been developing remdesivir for years as a viral treatment, with millions in U.S. funding, before it was tried for coronavirus. The consumer group Public Citizen estimates that at least $70 million in U.S. public funding went to develop remdesivir.

On Wednesday, Gilead said its supply of remdesivir should increase by the end of September and meet global demand after that. It said some countries should have enough for current needs, from the supply they received for patient testing and other programs.

Gilead has said it expects to spend more than $1 billion by year’s end on testing and manufacturing of remdesivir.

Dr. Penny Ward of King’s College London, noted that many countries have legal provisions that allow them to prohibit the exportation of drugs to other countries during an emergency.

“It is unreasonable to expect that the U.S. government should deny their population access to drugs manufactured in the USA,” she said.

Ward pointed out that another drug that may help people with severe COVID-19, the cheap steroid dexamathasone, is long off-patent and available globally.

The U.S. has the worst coronavirus outbreak in the world, with 2.6 million reported infected and 127,000 confirmed virus-related deaths, according to a tally by Johns Hopkins University. To date, COVID-19 has sickened more than 10.5 million people worldwide, killing around 512,000, according Johns Hopkins.

Numerous countries including Britain, France, Germany, Netherlands and the U.S. have struck deals with drugmakers to have millions of doses of experimental vaccines delivered before they are licensed. British politicians have said if a vaccine currently being developed by Oxford University and manufactured by AstraZeneca is proven to work, Britons will be first in line to get it.

___

AP writers Jill Lawless in London, Jan M. Olsen in Copenhagen and Linda A. Johnson in Fairless Hills, Pennsylvania, contributed to this report.

___

Follow AP pandemic coverage at http://apnews.com/VirusOutbreak and https://apnews.com/UnderstandingtheOutbreak.

Maria Cheng, The Associated Press

Coronavirus

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

robbery
UPDATE: Suspect identified in early morning shooting

Rimbey RCMP had responded to a complaint of an armed robbery at the Bluffton City General Store

Health Minister Tyler Shandro and Dr. Deena Hinshaw, the chief medical officer of health, receive flu shot. Photo via Government of Alberta
COVID-19: One more death in central zone

Ponoka County on province’s watchlist

Many rural municipalities were concerned about a proposed reduction to their industrial revenues, but Alberta’s Municipal Affairs minister has come up with an alternative solution. (Photo contributed)
Province and rural municipalities agree on a plan to support Alberta’s energy industry

Creating new wells or pipelines would result in a three year ‘tax holiday’

The influenza vaccine will be available at no cost starting Monday in Alberta. “The more that we can avoid influenza-related tests, emergency visits and hospitalizations, the stronger our system will be to support those with COVID-19 and all other health needs," says Dr. Deena Hinshaw, the province's chief medical officer of health. (AP Photo/Ted S. Warren)
Hinshaw urges Albertans to get flu shot as COVID cases jump by 332

Alberta’s central zone now has 132 active COVID-19 cases

The Bellows family on vacation last year in Mexico. L-R: Angel, Ryan, Darrel, Grace and Michael. (Photo submitted)
Rimbey community rallying behind family after cancer diagnosis

Michael Bellows, 12, a ‘strong, resilient kid’ says father

In this photo provided by Shannon Kiss, smoke from the CalWood Fire billows, Sunday, Oct. 18, 2020, as seen from Gunbarrel, Colo. (Shannon Kiss via AP)
‘First guys out:’ Western Canadian air tanker fleet busy despite drop in wildfires

CEO believes wildfires have become more dangerous in recent years as people live closer to where they start

A passer-by walks past a COVID-19 testing clinic in Montreal, Friday, Oct. 16, 2020. THE CANADIAN PRESS/Ryan Remiorz
Canada ‘yet to see’ deaths due to recent COVID surge as cases hit 200,000

Much of the increase in case numbers can be attributed to Ontario and Quebec

Executive Director of Agape Kate Halas (left) receives $1000 from Sgt. Eric Christensen (right) on behalf of Agape. Photo/ Shaela Dansereau.
Former Wetaskiwin Peace Officer wins provincial award; gives back to Wetaskiwin community

Eric Christensen has won the Alberta Association of Community Peace Officers Award of Excellence.

Agriculture Minister Devin Dreeshen (Alberta government photo)
Big boost for Alberta college agriculture research

The $2-million agreement to benefit Lethbridge College’s applied research team

Grant and Barbara Howse, in quarantine in Invermere. Mike Turner photo
Denied entry into U.S., Canadian couple still forced to quarantine for 2 weeks

The rules around crossing the U.S. border led to a bizarre situation for an Invermere couple

Employee Sophia Lovink shows off a bag of merchandise in Toronto on Thursday, June 11, 2020. (THE CANADIAN PRESS/Nathan Denette)
Canada gets C-average grade on 2nd year of cannabis legalization

Cannabis Council of Canada releases report card on federal government and legalization

Canadian and American flags fly near the Ambassador Bridge at the Canada-USA border crossing in Windsor, Ont. on Saturday, March 21, 2020. Restrictions on non-essential travel between Canada and the United States are being extended until at least Nov. 21. THE CANADIAN PRESS/Rob Gurdebeke
Non-essential travel restrictions at Canada-U.S. border extended to at least Nov. 21

The restrictions do not apply to those providing essential services in either country

(The Canadian Perss)
Banff wolves have lower survival rate due to hunting, trapping outside park boundary

Researchers looked at 72 radio-collared wolves in the national park from 1987 to August 2019

Democratic presidential candidate and former Vice President Joe Biden speaks at Miramar Regional Park in Miramar, Fla., Tuesday, Oct. 13, 2020. Alberta Premier Jason Kenney is still hopeful about the Keystone pipeline if there’s a change in government in the U.S. next month, saying Alberta has been engaging with American officials from both sides of the aisle. THE CANADIAN PRESS/AP-Carolyn Kaster
Alberta premier says he’s still hopeful about Keystone, even if Biden elected

The Alberta government has agreed to invest about US$1.1 billion as equity in the project

Most Read